Article
Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.
Current pharmaceutical design - 1 Jan 2005
Shimizu Wataru, Aiba Takeshi, Antzelevitch Charles
Abstract excerpt
Seven forms of congenital long QT syndrome (LQTS) caused by mutations in ion channel genes have been identified. Genotype-phenotype correlation in clinical and experimental studies involving arterially-perfused canine left ventricular wedges suggest that beta-blockers are protective in LQT1, less so in LQT2, but not protective in LQT3. A class IB sodium channel blocker, mexiletine, is most effective in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
